{
  "id": "cluster_5_doc2",
  "content": "Provider report from Dr. Ellison at Crestview Medical Oncology details treatment protocol adjustments for patient ID#3971-882K-55. The patient's combination immunotherapy regimen was modified on 11/03/2023 due to elevated liver enzymes, transitioning from IL-2 to interferon-alpha treatment under research protocol ONC-2023-441.",
  "metadata": {
    "format": "provider_report"
  }
}